HIV prevention among Latina transgender women who have sex with men: Evaluation of a locally developed intervention

ICR 202106-0920-005

OMB: 0920-1266

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form and Instruction
Modified
Form and Instruction
Modified
Form and Instruction
Modified
Form and Instruction
Modified
Supporting Statement A
2021-06-24
Supporting Statement B
2021-06-24
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2021-06-21
Supplementary Document
2019-02-25
Supplementary Document
2019-02-25
Supplementary Document
2019-02-25
Supplementary Document
2019-02-25
Supplementary Document
2019-02-25
ICR Details
0920-1266 202106-0920-005
Received in OIRA 201902-0920-019
HHS/CDC 0920-1266
HIV prevention among Latina transgender women who have sex with men: Evaluation of a locally developed intervention
Revision of a currently approved collection   No
Regular 06/24/2021
  Requested Previously Approved
24 Months From Approved 06/30/2021
365 365
154 171
0 0

The purpose of this study is to evaluate the efficacy of ChiCAS (Chicas Creando Acceso a la Salud [Chicas: Girls Creating Access to Health]), a Spanish language intervention that provides HIV prevention services to Hispanic/Latina adult transgender women. The information collected through this study will be used to evaluate whether exposure to the ChiCAS intervention results in improvements in participants' self-reported HIV prevention behaviors, beliefs and attitudes. This study will use a randomized delayed-intervention comparison group design to compare pre- (baseline) and post-intervention (6-month) levels of HIV risk among participants who have received the intervention and participants who have not yet received the intervention (delayed intervention group). The proposed Revision (2021) seeks approval to continue information collection activities that were halted due to the COVID pandemic, as well as for removal of redundant questions from the follow-up assessment, and for expansion of the recruitment area to metropolitan areas adjacent to North Carolina.

US Code: 42 USC 241 Name of Law: U.S. PHSA
  
None

Not associated with rulemaking

  86 FR 11533 02/25/2021
86 FR 33297 06/24/2021
Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 365 365 0 0 0 0
Annual Time Burden (Hours) 154 171 0 -17 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
Yes
Miscellaneous Actions
Revision of 0920-1266 includes removal of redundant questions and division of survey into Baseline and FollowUp resulting in decreased burden.

$695,535
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
No
Jeffrey Zirger 404 639-7118 wtj5@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/24/2021


© 2024 OMB.report | Privacy Policy